[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Nausea And Vomiting Treatment Industry Research Report 2023

August 2023 | 92 pages | ID: NE9D6563FC90EN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report aims to provide a comprehensive presentation of the global market for Nausea And Vomiting Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nausea And Vomiting Treatment.

The Nausea And Vomiting Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nausea And Vomiting Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nausea And Vomiting Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Merck & Co. Inc.
  • Helsinn Group
  • Unimed Pharmaceuticals (AbbVie Inc.)
  • Kyowa Kirin
  • Sanofi
  • Qilu Pharma
  • Teva Pharmaceutical Industries Ltd.
  • Taiji group
  • Novartis
  • Heron Therapeutics
  • Atnahs Pharma UK Limited
  • Mylan
  • Duchesnay
  • Tesaro
Product Type Insights

Global markets are presented by Nausea And Vomiting Treatment type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Nausea And Vomiting Treatment are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

Nausea And Vomiting Treatment segment by Type
  • Serotonin Receptor Antagonist
  • Neurokinin NK1 Receptor Antagonist
  • Others
Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the Nausea And Vomiting Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Nausea And Vomiting Treatment market.

Nausea And Vomiting Treatment Segment by Application
  • CINV
  • PONV
  • Motion Sickness
  • Pregnancy
  • Others
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Nausea And Vomiting Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nausea And Vomiting Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Nausea And Vomiting Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Nausea And Vomiting Treatment industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nausea And Vomiting Treatment.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Nausea And Vomiting Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Nausea And Vomiting Treatment by Type
  2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
  1.2.2 Serotonin Receptor Antagonist
  1.2.3 Neurokinin NK1 Receptor Antagonist
  1.2.4 Others
2.3 Nausea And Vomiting Treatment by Application
  2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
  2.3.2 CINV
  2.3.3 PONV
  2.3.4 Motion Sickness
  2.3.5 Pregnancy
  2.3.6 Others
2.4 Assumptions and Limitations

3 NAUSEA AND VOMITING TREATMENT BREAKDOWN DATA BY TYPE

3.1 Global Nausea And Vomiting Treatment Historic Market Size by Type (2018-2023)
3.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2023-2028)

4 NAUSEA AND VOMITING TREATMENT BREAKDOWN DATA BY APPLICATION

4.1 Global Nausea And Vomiting Treatment Historic Market Size by Application (2018-2023)
4.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2018-2023)

5 GLOBAL GROWTH TRENDS

5.1 Global Nausea And Vomiting Treatment Market Perspective (2018-2029)
5.2 Global Nausea And Vomiting Treatment Growth Trends by Region
  5.2.1 Global Nausea And Vomiting Treatment Market Size by Region: 2018 VS 2022 VS 2029
  5.2.2 Nausea And Vomiting Treatment Historic Market Size by Region (2018-2023)
  5.2.3 Nausea And Vomiting Treatment Forecasted Market Size by Region (2024-2029)
5.3 Nausea And Vomiting Treatment Market Dynamics
  5.3.1 Nausea And Vomiting Treatment Industry Trends
  5.3.2 Nausea And Vomiting Treatment Market Drivers
  5.3.3 Nausea And Vomiting Treatment Market Challenges
  5.3.4 Nausea And Vomiting Treatment Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top Nausea And Vomiting Treatment Players by Revenue
  6.1.1 Global Top Nausea And Vomiting Treatment Players by Revenue (2018-2023)
  6.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2018-2023)
6.2 Global Nausea And Vomiting Treatment Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Nausea And Vomiting Treatment Head office and Area Served
6.4 Global Nausea And Vomiting Treatment Players, Product Type & Application
6.5 Global Nausea And Vomiting Treatment Players, Date of Enter into This Industry
6.6 Global Nausea And Vomiting Treatment Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America Nausea And Vomiting Treatment Market Size (2018-2029)
7.2 North America Nausea And Vomiting Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Nausea And Vomiting Treatment Market Size by Country (2018-2023)
7.4 North America Nausea And Vomiting Treatment Market Size by Country (2024-2029)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe Nausea And Vomiting Treatment Market Size (2018-2029)
8.2 Europe Nausea And Vomiting Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Nausea And Vomiting Treatment Market Size by Country (2018-2023)
8.4 Europe Nausea And Vomiting Treatment Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific Nausea And Vomiting Treatment Market Size (2018-2029)
9.2 Asia-Pacific Nausea And Vomiting Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Nausea And Vomiting Treatment Market Size by Country (2018-2023)
9.4 Asia-Pacific Nausea And Vomiting Treatment Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia

10 LATIN AMERICA

10.1 Latin America Nausea And Vomiting Treatment Market Size (2018-2029)
10.2 Latin America Nausea And Vomiting Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Nausea And Vomiting Treatment Market Size by Country (2018-2023)
10.4 Latin America Nausea And Vomiting Treatment Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Nausea And Vomiting Treatment Market Size (2018-2029)
11.2 Middle East & Africa Nausea And Vomiting Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2018-2023)
11.4 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE

12 PLAYERS PROFILED

11.1 Merck & Co. Inc.
  11.1.1 Merck & Co. Inc. Company Detail
  11.1.2 Merck & Co. Inc. Business Overview
  11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Introduction
  11.1.4 Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.1.5 Merck & Co. Inc. Recent Development
11.2 Helsinn Group
  11.2.1 Helsinn Group Company Detail
  11.2.2 Helsinn Group Business Overview
  11.2.3 Helsinn Group Nausea And Vomiting Treatment Introduction
  11.2.4 Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.2.5 Helsinn Group Recent Development
11.3 Unimed Pharmaceuticals (AbbVie Inc.)
  11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Detail
  11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
  11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Introduction
  11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Development
11.4 Kyowa Kirin
  11.4.1 Kyowa Kirin Company Detail
  11.4.2 Kyowa Kirin Business Overview
  11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Introduction
  11.4.4 Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.4.5 Kyowa Kirin Recent Development
11.5 Sanofi
  11.5.1 Sanofi Company Detail
  11.5.2 Sanofi Business Overview
  11.5.3 Sanofi Nausea And Vomiting Treatment Introduction
  11.5.4 Sanofi Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.5.5 Sanofi Recent Development
11.6 Qilu Pharma
  11.6.1 Qilu Pharma Company Detail
  11.6.2 Qilu Pharma Business Overview
  11.6.3 Qilu Pharma Nausea And Vomiting Treatment Introduction
  11.6.4 Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.6.5 Qilu Pharma Recent Development
11.7 Teva Pharmaceutical Industries Ltd.
  11.7.1 Teva Pharmaceutical Industries Ltd. Company Detail
  11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
  11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Introduction
  11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.8 Taiji group
  11.8.1 Taiji group Company Detail
  11.8.2 Taiji group Business Overview
  11.8.3 Taiji group Nausea And Vomiting Treatment Introduction
  11.8.4 Taiji group Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.8.5 Taiji group Recent Development
11.9 Novartis
  11.9.1 Novartis Company Detail
  11.9.2 Novartis Business Overview
  11.9.3 Novartis Nausea And Vomiting Treatment Introduction
  11.9.4 Novartis Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.9.5 Novartis Recent Development
11.10 Heron Therapeutics
  11.10.1 Heron Therapeutics Company Detail
  11.10.2 Heron Therapeutics Business Overview
  11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Introduction
  11.10.4 Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.10.5 Heron Therapeutics Recent Development
11.11 Atnahs Pharma UK Limited
  11.11.1 Atnahs Pharma UK Limited Company Detail
  11.11.2 Atnahs Pharma UK Limited Business Overview
  11.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Introduction
  11.11.4 Atnahs Pharma UK Limited Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.11.5 Atnahs Pharma UK Limited Recent Development
11.12 Mylan
  11.12.1 Mylan Company Detail
  11.12.2 Mylan Business Overview
  11.12.3 Mylan Nausea And Vomiting Treatment Introduction
  11.12.4 Mylan Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.12.5 Mylan Recent Development
11.13 Duchesnay
  11.13.1 Duchesnay Company Detail
  11.13.2 Duchesnay Business Overview
  11.13.3 Duchesnay Nausea And Vomiting Treatment Introduction
  11.13.4 Duchesnay Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.13.5 Duchesnay Recent Development
11.14 Tesaro
  11.14.1 Tesaro Company Detail
  11.14.2 Tesaro Business Overview
  11.14.3 Tesaro Nausea And Vomiting Treatment Introduction
  11.14.4 Tesaro Revenue in Nausea And Vomiting Treatment Business (2017-2022)
  11.14.5 Tesaro Recent Development

13 REPORT CONCLUSION

14 DISCLAIMER



More Publications